Key stats
About TIGER NASDAQ BIO
Expense ratio
0.30%
Home page
Inception date
Aug 26, 2014
ISIN
KR7203780002
The TIGER NASDAQ BIO ETF seeks investment results that corresponds generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (KRW).
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.03%
Health Technology97.36%
Commercial Services1.33%
Health Services0.35%
Bonds, Cash & Other0.97%
Cash0.97%
Stock breakdown by region
North America99.96%
Europe0.04%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history